Hempire

Kadenwood with Garrett Bain, President of EcoGen and Chief Commercial Officer of Kadenwood, LLC. today on Hempire only Cannabis Radio. Kadenwood was formed to create exciting brands for the future, with both consumer and industrial products shaping CBD into a trusted, mainstream wellness category. To ensure success, Kadenwood merged a team of proven industry heavyweights in CPG marketing and innovation with a seed-to-shelf CBD farm group. Garrett is a trailblazer in the hemp and CBD space. He led sales and marketing for GenCanna from the early stages to one of the largest players in the global market. Achieving revenue growth of over $100m in three years. His focus on integrating mainstream business practices into the hemp-derived CBD space helped to validate the industry and foster growth across multiple channels. Prior to hemp, Garrett was a VP of Sales in consumer goods distribution, servicing the global leaders of big-box retail and eCommerce. His execution-oriented, “lead from the front” style, can be attributed to his time serving as a Special Operations Team Leader with the 75th Ranger Regiment. He is a combat veteran who pursues the objective with a relentless commitment to his team and achieving success.

Pivital Labs With Dr. Rachel Knox, MD, MBA today on Hempire only on Cannabis Radio! Dr. Rachel Knox is a cannabinoid medicine specialist and clinical endocannabinologist who received her medical and business degrees from Tufts School of Medicine after completing her undergraduate studies at Duke. She trained in family and integrative medicine at Carolinas Health Center before pursuing additional study in the areas of functional medicine, cannabinology, and endocannabinology. Along with her family, Dr. Rachel founded Doctors Knox, Inc., American Cannabinoid Clinics, and Pivital Edu to advance education and clinical care in cannabinoid medicine and endocannabinology. Dr. Rachel is also a policy and regulatory consultant on cannabis and psychedelic health equity, and her commitment to reform extends into educating communities of color about the role entheogens can play in addressing the Minority Health Disparity Gap, and the broader way in which cannabis can impact the total wellbeing of these communities through creating health equity.

She is chair of the Association for Cannabis Health Equity and Medicine (ACHEM) and CHEM Allyance, immediate past chair of the Oregon Cannabis Commission, member of Portland's Cannabis Policy Oversight Team, member of Oregon’s Psilocybin Advisory Board, board member for Cannabis Regulators of Color Coalition (CRCC), Doctors for Cannabis Regulation (DFCR), and Minority Cannabis Business Association (MCBA), advisory board member of the American Academy of Cannabinoid Medicine (AACM), co-founder and president of the Cannabis Health Equity Movement™, and board member for Nuleaf PDX. Dr. Rachel Knox, Endocannabinologist and Cannabinoid Medicine Specialist. Dr. Rachel Knox, Endocannabinologist and board member for Nuleaf PDX.

Wild Wellness with Rebecca Grace Andrews an herbalist & ecotherapist. Rebecca offers health education for any condition, specializing in wellness education for those with Crohn's, ulcerative colitis, autoimmune conditions, gut conditions, ADHD, Lyme disease, depression, and/or anxiety. She also provides solutions for overall low health characterized by frequent illness and fatigue. Plus peaceful-parenting and/or homeschool coaching.

Lipolaser of Kentucky is engaged in the business of Anti-Aging and Wellness Clinics in Indiana, Ohio, and Kentucky. We are joined today by the owner of Lipolaser Kentucky Dr. Robert Arrasmith. One of the modalities that they are employing is the new Laser Lipo, Body Contouring System. This is a non-invasive, painless, cold red laser, when placed on the skin, liquefies body fat. Three treatments a week for four weeks results in a 9 to 12-inch body contouring loss and a 12 to 15-pound body fat loss.

Cannabis and Women's Health Round Table Part 2 is the second part of a 2 part episode where we are joined by 2 amazing guests. Mallory Loftin, a research health scientist at VA San Diego Healthcare System, the Center of Excellence for Stress and Mental Health. As well as Brianna Altman, a Doctoral Student at The University at Albany, SUNY. Dr. Loflin received her Ph.D. in Clinical Psychology from the University at Albany, the State University of New York in 2016.

Cannabis and Women's Health Round Table Part 1 is the first part of a 2 part episode where we are joined by 2 amazing guests. Mallory Loftin, a research health scientist at VA San Diego Healthcare System, the Center of Excellence for Stress and Mental Health. As well as Brianna Altman, a Doctoral Student at The University at Albany, SUNY.

Andrew has dedicated his career to understanding the pharmaceutical utility of the biochemical makeup of both terrestrial and marine invertebrates. He received both his Ph.D. and Master’s degree from Florida Atlantic University under the subject area of Natural Products Chemistry. Post-Graduation, Andrew was instrumental in developing a cannabis testing facility in Massachusetts where he served as director, doing safety testing as-well-as in-vivo and in-vitro testing of cannabinoids on both large and small species. Since then Andrew has been involved in both west coast and east coast cannabis lab operations and is currently serving as Chief Scientific Officer for Green scientific labs Florida’s premier ISO accredited testing facility in Florida. The agricultural boom delivered a massive rise in the number of producers.

Andrew has dedicated his career to understanding the pharmaceutical utility of the biochemical makeup of both terrestrial and marine invertebrates. He received both his Ph.D. and Master’s degree from Florida Atlantic University under the subject area of Natural Products Chemistry. Post-Graduation, Andrew was instrumental in developing a cannabis testing facility in Massachusetts where he served as director, doing safety testing as-well-as in-vivo and in-vitro testing of cannabinoids on both large and small species. Since then Andrew has been involved in both west coast and east coast cannabis lab operations and is currently serving as Chief Scientific Officer for Green scientific labs Florida’s premier ISO accredited testing facility in Florida. The agricultural boom delivered a massive rise in the number of producers. The non-regulated state of has essentially allowed manufacturers and distributors to slap impressive-looking labels on their products, thus marketing and selling these products however they please. Quality manufacturers know that an industry without rules and regulations will quickly become overrun with scams, false advertising, and out-and-out lies, which pose several challenges for consumers to make educated purchases or receive quality, reliable information. Good, honest companies with quality products are rapidly seeking ways to overcome the competition and rise to the top, and most of these companies are accomplishing this through third-party testing. These honorable companies know they are manufacturing and selling quality products, and they are not scared to have an unbiased, outside source to verify their integrity. The goal behind independent third-party lab testing is to have a neutral, unbiased source examine the content and quality of a company’s products.

How to buy CBD with Staci Gruber. Staci Gruber, Ph.D., is the director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital and an associate professor of Psychiatry. She primarily focuses on the neurocognitive effects of substance use, particularly marijuana. This includes medical marijuana and recreational marijuana. Most of her recent work has explored the effects of recreational marijuana use on younger patients. Why proper education and information needs to be out there to the public so that they get their hands on the right quality and quantity of CBD from the right producers. Empowering the supplemental consumer through direct access to product transparency.

CBD Education 101 with Staci Gruber, Ph.D. Staci is the director of the Cognitive and Clinical Neuroimaging Core and director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital. She is an associate professor of psychiatry at Harvard Medical School. Her research focuses on the application of neurocognitive models and neuroimaging to better characterize risk factors for substance misuse and psychiatric conditions. Dr. Gruber directs the Marijuana Investigations for Neuroscientific Discovery (MIND) Program, designed to support a wide range of studies that generate ecologically valid, empirically sound data regarding medical cannabis use. Through these investigations, MIND examines the unique and synergistic effects of cannabis and its constituents to determine the efficacy of cannabinoids for specific conditions and diseases and to clarify the overall impact of cannabinoid-based treatments on physical and mental health.